258 related articles for article (PubMed ID: 26997302)
1. Myeloma bone and extra-medullary disease: Role of PET/CT and other whole-body imaging techniques.
Rubini G; Niccoli-Asabella A; Ferrari C; Racanelli V; Maggialetti N; Dammacco F
Crit Rev Oncol Hematol; 2016 May; 101():169-83. PubMed ID: 26997302
[TBL] [Abstract][Full Text] [Related]
2. Imaging of Multiple Myeloma.
Kosmala A; Bley T; Petritsch B
Rofo; 2019 Sep; 191(9):805-816. PubMed ID: 31185511
[TBL] [Abstract][Full Text] [Related]
3. Whole body magnetic resonance with diffusion weighted sequence with body signal suppression compared to (18)F-FDG PET/CT in newly diagnosed lymphoma.
Ferrari C; Minoia C; Asabella AN; Nicoletti A; Altini C; Antonica F; Ficco M; Guarini A; Maggialetti N; Rubini G
Hell J Nucl Med; 2014; 17 Suppl 1():40-9. PubMed ID: 24392468
[TBL] [Abstract][Full Text] [Related]
4. Whole-body imaging of bone marrow.
Schmidt GP; Reiser MF; Baur-Melnyk A
Semin Musculoskelet Radiol; 2009 Jun; 13(2):120-33. PubMed ID: 19455475
[TBL] [Abstract][Full Text] [Related]
5. Comparative study of fluorodeoxyglucose positron emission tomography and magnetic resonance imaging for the detection of spinal bone marrow infiltration in untreated patients with multiple myeloma.
Hur J; Yoon CS; Ryu YH; Yun MJ; Suh JS
Acta Radiol; 2008 May; 49(4):427-35. PubMed ID: 18415787
[TBL] [Abstract][Full Text] [Related]
6. Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma.
Jamet B; Zamagni E; Nanni C; Bailly C; Carlier T; Touzeau C; Michaud AV; Moreau P; Bodet-Milin C; Kraeber-Bodere F
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32751375
[TBL] [Abstract][Full Text] [Related]
7. Whole-body magnetic resonance imaging and positron emission tomography-computed tomography in oncology.
Schmidt GP; Kramer H; Reiser MF; Glaser C
Top Magn Reson Imaging; 2007 Jun; 18(3):193-202. PubMed ID: 17762383
[TBL] [Abstract][Full Text] [Related]
8. Imaging in multiple myeloma: How? When?
Zamagni E; Tacchetti P; Cavo M
Blood; 2019 Feb; 133(7):644-651. PubMed ID: 30587527
[TBL] [Abstract][Full Text] [Related]
9. (18)F-FDG dynamic PET/CT in patients with multiple myeloma: patterns of tracer uptake and correlation with bone marrow plasma cell infiltration rate.
Sachpekidis C; Mai EK; Goldschmidt H; Hillengass J; Hose D; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2015 Jun; 40(6):e300-7. PubMed ID: 25783508
[TBL] [Abstract][Full Text] [Related]
10. Whole-body MRI, FDG-PET/CT, and bone marrow biopsy, for the assessment of bone marrow involvement in patients with newly diagnosed lymphoma.
Albano D; Patti C; Lagalla R; Midiri M; Galia M
J Magn Reson Imaging; 2017 Apr; 45(4):1082-1089. PubMed ID: 27603267
[TBL] [Abstract][Full Text] [Related]
11. The Role of Imaging in the Treatment of Patients With Multiple Myeloma in 2016.
Terpos E; Dimopoulos MA; Moulopoulos LA
Am Soc Clin Oncol Educ Book; 2016; 35():e407-17. PubMed ID: 27249748
[TBL] [Abstract][Full Text] [Related]
12. Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography.
Schabel C; Horger M; Kum S; Weisel K; Fritz J; Ioanoviciu SD; Bier G
Eur J Radiol; 2016 Dec; 85(12):2195-2199. PubMed ID: 27842666
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic performance of
Ishiguchi H; Ito S; Kato K; Sakurai Y; Kawai H; Fujita N; Abe S; Narita A; Nishio N; Muramatsu H; Takahashi Y; Naganawa S
Ann Nucl Med; 2018 Jun; 32(5):348-362. PubMed ID: 29667143
[TBL] [Abstract][Full Text] [Related]
14. Skeletal Survey in Multiple Myeloma: Role of Imaging.
Spinnato P; Filonzi G; Conficoni A; Facchini G; Ponti F; Sambri A; De Paolis M; Cavo M; Salizzoni E; Nanni C
Curr Med Imaging; 2021; 17(8):956-965. PubMed ID: 33573573
[TBL] [Abstract][Full Text] [Related]
15. Whole-Body Low-Dose CT in Multiple Myeloma: Diagnostic Value of Appendicular Medullary Patterns of Attenuation.
Koutoulidis V; Terpos E; Klapa I; Cheliotis G; Ntanasis-Stathopoulos I; Boultadaki A; Gavriatopoulou M; Kastritis E; Dimopoulos MA; Moulopoulos LA
AJR Am J Roentgenol; 2021 Mar; 216(3):742-751. PubMed ID: 33439048
[No Abstract] [Full Text] [Related]
16. [Imaging techniques in multiple myeloma].
Ozaki S
Nihon Rinsho; 2007 Dec; 65(12):2261-7. PubMed ID: 18069271
[TBL] [Abstract][Full Text] [Related]
17. Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria.
Ormond Filho AG; Carneiro BC; Pastore D; Silva IP; Yamashita SR; Consolo FD; Hungria VTM; Sandes AF; Rizzatti EG; Nico MAC
Radiographics; 2019; 39(4):1077-1097. PubMed ID: 31283452
[TBL] [Abstract][Full Text] [Related]
18. Supplemental value of diffusion-weighted whole-body imaging with background body signal suppression (DWIBS) technique to whole-body magnetic resonance imaging in detection of bone metastases from thyroid cancer.
Sakurai Y; Kawai H; Iwano S; Ito S; Ogawa H; Naganawa S
J Med Imaging Radiat Oncol; 2013 Jun; 57(3):297-305. PubMed ID: 23721138
[TBL] [Abstract][Full Text] [Related]
19. Whole body MRI with qualitative and quantitative analysis of DWI for assessment of bone marrow involvement in lymphoma.
Balbo-Mussetto A; Saviolo C; Fornari A; Gottardi D; Petracchini M; Macera A; Lario CV; Gallo T; Tarella C; Cirillo S
Radiol Med; 2017 Aug; 122(8):623-632. PubMed ID: 28421406
[TBL] [Abstract][Full Text] [Related]
20. How do we image patients with multiple myeloma and precursor states?
Chakraborty R; Hillengass J; Lentzsch S
Br J Haematol; 2023 Nov; 203(4):536-545. PubMed ID: 37217164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
